Skip to main content
. 2021 Jun 10;2021:6616547. doi: 10.1155/2021/6616547

Figure 3.

Figure 3

Carvacrol treatment inactivates the AKT/mTOR pathway and NALP3 inflammasome in OSCC cells. (a) Western blot was utilized to examine the expression of (b) AKT1, (c) p-AKT1, (d) mTOR, (e) p-mTOR, and (f) NALP3 in CAL-27 cells treated with TBHQ and/or Carvacrol. For each experiment, n = 3. ∗∗∗∗p < 0.0001.